Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression
Article in International Journal of Immunopathology and Pharmacology (January 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Curcumin with nanocarriers as cancer therapeutics: An update
Conference proceeding in AIP Conference Proceedings (September 2023)
Down-regulated ATF3 Promotes Renal Clear Cell Carcinoma Progression Through PAXIP1-AS2 and OIP5-AS1/ hsa-miR-221-3p/ATF3 Axis Regulation of Endoplasmic Reticulum Stress
Preprint in Research Square (May 2023)